Steven H. Collis has led Cencora, previously known as AmerisourceBergen, since becoming CEO on July 1, 2011. His journey with the company started back in 1994, working his way up through various key positions, including President and Chief Operating Officer....

Steven H. Collis has led Cencora, previously known as AmerisourceBergen, since becoming CEO on July 1, 2011. His journey with the company started back in 1994, working his way up through various key positions, including President and Chief Operating Officer. Under his leadership, Cencora has achieved impressive financial performance, with a total compensation reaching as high as $17.45 million in 2023, primarily driven by significant bonuses linked to the company's successes. Interestingly, Collis has seen considerable fluctuations in his stock holdings, which were valued at approximately $96.91 million at one point in early 2024, showcasing his strong alignment with shareholder interests. His compensation philosophy emphasizes pay-for-performance, tying his earnings to metrics like adjusted earnings per share and operating income. In addition to his role in Cencora, Collis is known for his strategic vision and decision-making. He has a significant transitional role as he prepares to step into an Executive Chairman position after a successful tenure. Knowing that his decisions impact both company growth and employee welfare gives a sense of responsibility that he carries forward. This blend of leadership and accountability marks Steven H. Collis as a notable figure in the pharmaceutical distribution landscape.